ZURA
Zura Bio LtdCompany Information
- Company Name
- Zura Bio Ltd
- CIK
- CIK0001855644
- Category
- <br>Emerging growth company
- Ticker: Exchange
- ZURA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- ZURA
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-02-26
- Last sale
- 2024-11-25
- Shares purchased (TTM)
- 2,000,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 73,062,163
- Shares outstanding
- 126,803,970
- Ownership
- 57.62%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- 12.05%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 205 | 226 | 109 | 139 | 154 | 171 | 176 | 188 | 188 | 90 | 100 | 104 | ||||||
| Other Prepaid Expense Current | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 5 | 1 | 3 | 3 | 2 | 1 | 2 | 1 | - | - | 1 | - | ||||||
| Assets Current | 211 | 227 | 112 | 142 | 157 | 172 | 179 | 189 | 189 | 90 | 101 | 105 | ||||||
| Deferred Costs | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Other Assets Noncurrent | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | - | - | - | - | ||||||
| Assets | 213 | 229 | 114 | 144 | 158 | 172 | 180 | 189 | 190 | 90 | 101 | 105 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 16 | 12 | 12 | 25 | 19 | 21 | 20 | 18 | 15 | 15 | 20 | 17 | ||||||
| Liabilities Current | 16 | 12 | 12 | 25 | 19 | 21 | 20 | 18 | 15 | 15 | 20 | 17 | ||||||
| Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent | - | - | - | - | - | - | - | - | 2 | 2 | 1 | 2 | ||||||
| Liabilities | 16 | 12 | 12 | 25 | 19 | 21 | 20 | 18 | 17 | 16 | 21 | 19 | ||||||
Temporary Equity | ||||||||||||||||||
| Redeemable Noncontrolling Interest Equity Carrying Amount | - | - | - | 9 | 12 | 12 | 12 | 16 | 14 | 12 | 19 | 21 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 472 | 466 | 326 | 316 | 315 | 312 | 303 | 295 | 278 | 172 | 163 | 158 | ||||||
| Retained Earnings Accumulated Deficit | -275 | -249 | -225 | -207 | -189 | -173 | -156 | -142 | -122 | -111 | -103 | -95 | ||||||
| Stockholders Equity | 197 | 217 | 102 | 110 | 126 | 140 | 147 | 154 | 157 | 61 | 59 | 63 | ||||||
| Minority Interest | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Liabilities And Stockholders Equity | 213 | 229 | 114 | 144 | 158 | 172 | 180 | 189 | 190 | 90 | 101 | 105 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 95 | 95 | 74 | 65 | 62 | 68 | 65 | 65 | 64 | 44 | 44 | 43 | ||||||
| Shares Outstanding | 95 | 95 | 74 | 65 | 62 | 68 | 65 | 65 | 64 | 44 | 44 | 43 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | - | - | - | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialZura Bio Ltd (ZURA) — SEC Financial Statements & Analysis
Zura Bio Ltd (ZURA) is a biological products, (no diagnostic substances) company, incorporated in E9. Zura Bio Ltd trades on Nasdaq as: ZURA. Zura Bio Ltd (ZURA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, Zura Bio Ltd carries a market cap of $748.14M, a P/E ratio of -6.42x, a P/B ratio of 3.80x, an enterprise value of $747.94M, and an EV/EBITDA multiple of -8.07x. On profitability, it posts a Return on Equity (ROE) of -72.10%, a Return on Assets (ROA) of -62.74%, and a Return on Invested Capital (ROIC) of -57.44%. Per share, it reports EPS of $-0.92, diluted EPS of $-0.92, free cash flow per share of $-0.51, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 91.69% year-over-year and EPS growth of 42.54% year-over-year. On the balance sheet, it maintains a current ratio of 12.90x, a quick ratio of 12.57x, working capital of $194.18M, a debt-to-equity ratio of 0.08x, a debt ratio of 0.08, free cash flow of $-64.97M (TTM), and net debt of $-205.13K. Figures sourced from SEC EDGAR.
- Market Cap
- $748.14M
- P/E TTM
- -6.42x
- EPS TTM
- $-0.92
- P/B TTM
- 3.80x
- ROE TTM
- -72.10%
- ROA TTM
- -62.74%
- Debt To Equity
- 0.08x
- Free Cash Flow TTM
- $-64.97M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Zura Bio Ltd in?
Zura Bio Ltd (ZURA) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does ZURA trade on?
Zura Bio Ltd (ZURA) trades on the Nasdaq.
Where is Zura Bio Ltd incorporated?
Zura Bio Ltd is incorporated in Cayman Islands.
When was Zura Bio Ltd (ZURA)'s most recent SEC filing?
Zura Bio Ltd (ZURA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is ZURA's market cap?
Zura Bio Ltd (ZURA) has a market capitalization of $748.14M as of 2026-06-30.
What is ZURA's EPS (earnings per share)?
Zura Bio Ltd (ZURA)'s trailing twelve month EPS is $-0.92 as of 2026-06-30.
What is ZURA's ROE (return on equity)?
Zura Bio Ltd (ZURA)'s trailing twelve month Return on Equity (ROE) is -72.10% as of 2026-06-30.
What is ZURA's ROA (return on assets)?
Zura Bio Ltd (ZURA)'s trailing twelve month Return on Assets (ROA) is -62.74% as of 2026-06-30.
What is ZURA's ROIC (return on invested capital)?
Zura Bio Ltd (ZURA)'s trailing twelve month Return on Invested Capital (ROIC) is -57.44% as of 2026-06-30.
What is ZURA's EV/EBITDA?
Zura Bio Ltd (ZURA)'s trailing twelve month EV/EBITDA is -8.07x as of 2026-06-30.